Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome

Clinical trial NCT03232359 · COMPLETED

Trial details

NCT number: NCT03232359
Sponsor: AYMAN ABDELKADER MOHAMED ABDELKADER
Status: COMPLETED
Study type: OBSERVATIONAL

Pre-Eclampsia, Severe HELLP Syndrome Microangiopathy

Start date: 2015-01-01
Primary completion: 2015-12-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.